Biotage AB (publ) announced that while the business of the company continues to perform well, following consultation with the Board Tomas Blomquist will leave his role as CEO & President of the company with immediate effect. The Chairman of the Board, Torben Jørgensen, has been appointed by the Board of Directors as interim CEO while the process of recruiting a new CEO is finalized. As Torben Jørgensen takes on the role as interim CEO, he has resigned as Chairman of the Board but he will remain as a Board member.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
168 SEK | +0.24% | +5.00% | +25.65% |
Apr. 25 | Transcript : Biotage AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Biotage AB Approves a Dividend, Payable on May 3, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.65% | 1.23B | |
-15.28% | 19.22B | |
-44.98% | 2.63B | |
+17.00% | 1.86B | |
-0.51% | 1.66B | |
-13.90% | 1.05B | |
-21.76% | 894M | |
-3.53% | 740M | |
-20.73% | 687M | |
+6.37% | 497M |
- Stock Market
- Equities
- BIOT Stock
- News Biotage AB
- Biotage AB Announces CEO Changes